These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 577978

  • 1. Angiotensin II inhibition. Treatment of congestive cardiac failure in a high-renin hypertension.
    Gavras H, Flessas A, Ryan TJ, Brunner HR, Faxon DP, Gavras I.
    JAMA; 1977 Aug 22; 238(8):880-2. PubMed ID: 577978
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The significance of renin and angiotensin in renovascular hypertension in man.
    Fagard R, Amery A, Billiet L, Joossens JV, Lijnen P, Reybrouck T.
    Acta Clin Belg; 1979 Aug 22; 34(3):130-9. PubMed ID: 506622
    [No Abstract] [Full Text] [Related]

  • 4. [Hemodynamic effects of sar1-ala8-angiotensin in patients with renovascular hypertension (author's transl)].
    Philipp T, Zschierdrich H, Distler A.
    Klin Wochenschr; 1977 Sep 15; 55(18):917-9. PubMed ID: 916618
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Arterial hypertension and maintenance hemodialysis: effects of specific inhibition of angiotensin II by saralasin acetate].
    Mimran A, Deschodt G, Shaldon S, Barjon P, Mion C.
    Arch Mal Coeur Vaiss; 1978 Jul 15; 71 Spec No():19-24. PubMed ID: 101176
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Detection of renovascular hypertension with angiotensin II blockade.
    Baer L, Parra-Carrilo JZ, Radichevich I, Williams GS.
    Ann Intern Med; 1977 Mar 15; 86(3):257-60. PubMed ID: 842983
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hemodynamic correlates of saralasin: responsiveness in hypertension.
    Kem DC, Frohlich ED, de Carvalho JG, Dunn FG, Chrysant SG, Danisa K, Wambach G.
    Kidney Int Suppl; 1979 Mar 15; (9):S68-74. PubMed ID: 289866
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Angiotensin converting enzyme inhibition in patients with congestive heart failure.
    Gavras H, Faxon DP, Berkoben J, Brunner HR, Ryan TJ.
    Circulation; 1978 Nov 15; 58(5):770-6. PubMed ID: 699246
    [Abstract] [Full Text] [Related]

  • 19. Systemic hemodynamic and hormonal responses during angiotensin II blockade with saralasin.
    Roos JC, Geyskes GG, Boer P, Dorhout Mees EJ.
    J Cardiovasc Pharmacol; 1981 Nov 15; 3(5):1106-15. PubMed ID: 6168855
    [Abstract] [Full Text] [Related]

  • 20. [Hemodynamics, renin and aldosterone following angiotensin II blockade and sodium chloride deficiency in hypertensive subjects].
    Beyer J, Liebau G, Steiner B, Schick K, Hayduk K.
    Verh Dtsch Ges Kreislaufforsch; 1977 Nov 15; 43():212-3. PubMed ID: 613577
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.